Skip to main content
SpringerLink
Log in

Therapy-related acute nonlymphocytic leukemia: Clinical aspects

  • Guest Editorial
  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pedersen-Bjergaard J, Larsen S O: Incidence of acute nonlymphocytic leukemia, preleukemia and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin’s disease.New Engl J Med 307, 965 (1982).

    PubMed  CAS  Google Scholar 

  2. Coltman C A, Dixon D O: Second malignancies complicating Hodgkin’s disease: a Southwest Oncology Group 10-year follow-up.Cancer Treat Rep 66, 023 (1982).

    Google Scholar 

  3. Glicksman A S, Pajak T F, Gottlieb A, Nissen N, Stutzman L, Cooper M R: Second malignant neoplasms in patients successfully treated for Hodgkin’s disease: a Cancer and Leukemia Group B study.Cancer Treat Rep 66, 1035 (1982).

    PubMed  CAS  Google Scholar 

  4. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A, Bonadonna G: Second acute leukemia and other malignancies following treatment for Hodgkin’s disease.J clin Oncol 4, 830 (1986).

    PubMed  CAS  Google Scholar 

  5. Pedersen-Bjergaard J, Specht L, Larsen S O, Ersbøll J, Struck J, Hansen M M, Hansen H H, Nissen N I: Risk of therapy-related leukaemia and preleukaemia after Hodgkin’s disease.Lancet ii, 83 (1987).

    Article  Google Scholar 

  6. Tucker M A, Coleman C N, Cox R S, Varghese A, Rosenberg S A: Risk of second cancers after treatment for Hodgkin’s disease.New Engl J Med 318, 76 (1988).

    PubMed  CAS  Google Scholar 

  7. Greene M H, Young R C, Merrill J M, DeVita V T: Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin’s lymphoma.Cancer Res 43, 1891 (1983).

    PubMed  CAS  Google Scholar 

  8. Pedersen-Bjergaard J, Ersbøll J, Sørensen H M, Keiding N, Larsen S O, Philip P, Larsen M S, Schultz H, Nissen N I: Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin’s Iymphomas.Ann intern Med 103, 195 (1985).

    PubMed  CAS  Google Scholar 

  9. Berk P D, Goldberg J D, Silverstein M N, Weinfeld A, Donovan P B, Ellis J T, Landaw S A, Laszlo J, Najean Y, Pisciotta A V, Wasserman L R: Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.New Engl J Med 304, 441 (1981).

    PubMed  CAS  Google Scholar 

  10. Bergsagel D E, Bailey A J, Langley G R, MacDonald R N, White D F, Miller A B: The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia.New Engl J Med 301, 743 (1979).

    PubMed  CAS  Google Scholar 

  11. Kyle R A: Second malignancies associate with chemotherapy, in Perry M C, Yarbro J W (eds):Toxicity of Chemotherapy, p. 479. New York, Grune & Stratton (1984).

    Google Scholar 

  12. Pedersen-Bjergaard J, Nissen N I, Sørensen H M, Hou-Jensen K, Larsen M S, Ernst P, Ersbøll J, Knudtzon S, Rose C: Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (Dihydroxybusulfan).Cancer 45, 19 (1980).

    Article  PubMed  CAS  Google Scholar 

  13. Greene M H, Boice J D, Greer B E, Blessing J A, Dembo A J: Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer.New Engl J Med 307, 1416 (1982).

    PubMed  CAS  Google Scholar 

  14. Chak L Y, Sikic B I, Tucker M A, Horns R C, Cox R S: Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung.J. clin Oncol 2, 385 (1984).

    PubMed  CAS  Google Scholar 

  15. Pedersen-Bjergaard J, Østerlind K, Hansen M, Philip P, Pedersen A G, Hansen H H: Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung.Blood 66, 1393 (1985).

    PubMed  CAS  Google Scholar 

  16. Fisher B, Rockette H, Fisher E R, Wickerham D L, Redmond C, Brown A: Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.J clin Oncol 3, 1640 (1985).

    PubMed  CAS  Google Scholar 

  17. Redman J R, Vugrin D, Arlin Z A, Gee T S, Kempin S J, Godbold J H, Schottenfeld D, Clarkson B D: Leukemia following treatment of germ cell tumors in men.J clin Oncol 2, 1080 (1984).

    PubMed  CAS  Google Scholar 

  18. Boice J D, Green M H, Killen J Y, Ellenberg S S, Keehn R J, McFadden E, Chen T T, Fraumeni J F: Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).New Engl J Med 309, 1079 (1983).

    Article  PubMed  Google Scholar 

  19. Blayney D W, Longo D L, Young R C, Greene M H, Hubbard S M, Postal M G, Duffey P L, DeVita V T: Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease.New Engl J Med 316, 710 (1987).

    PubMed  CAS  Google Scholar 

  20. Stott H, Fox W, Girling D J, Stephens R J, Galton D A G: Acute leukaemia after busulphan.Br Med J 2, 1513 (1977).

    Article  PubMed  CAS  Google Scholar 

  21. Cuzick J, Erskine S, Edelman D, Galton D A G: A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis.Br J Cancer 55, 523 (1987).

    PubMed  CAS  Google Scholar 

  22. Greene M H, Harris E L, Gershenson D M, Malkasian G D, Melton L J, Dembo A J, Bennett J M, Moloney W C, Boice J D: Melphalan may be a more potent leukemogen than cyclophosphamide.Ann intern Med 105, 360 (1986).

    PubMed  CAS  Google Scholar 

  23. Boice J D, Day N E, Andersen Aet al.: Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries.J natn Cancer Inst 74, 955 (1985).

    Google Scholar 

  24. Rowley J D, Golomb H M, Vardiman J: Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas.Blood 50, 759 (1977).

    Google Scholar 

  25. Pedersen-Bjergaard J, Philip P, Mortensen B T, Ersbøll J, Jensen G, Panduro J, Thomsen M: Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results ofin vitro culture of bone marrow and HLA typing.Blood 57, 712 (1981).

    PubMed  CAS  Google Scholar 

  26. Rowley J D, Golomb H M, Vardiman J W: Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease.Blood 58, 759 (1981).

    PubMed  CAS  Google Scholar 

  27. Pedersen-Bjergaard J, Philip P, Pedersen N T, Hou-Jensen K, Svejgaard A, Jensen G, Nissen N I: Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases.Cancer 54, 452 (1984).

    Article  PubMed  CAS  Google Scholar 

  28. Kantarjian H M, Keating M J, Walters R S, Smith T L, Cork A, McCredie K B, Freireich E J: Therapyrelated leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.J clin Oncol 4, 1748 (1986).

    PubMed  CAS  Google Scholar 

  29. Vadhan-Raj S, Keating M, LeMaistre A, Hittelman W N, McCredie K, Trujillo J M, Broxmeyer H E, Hennly C, Gutterman J U: Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.New Engl J Med 317, 1545 (1987).

    PubMed  CAS  Google Scholar 

  30. O’Donnell M R, Nademanee A P, Snyder D S, Schmidt G M, Parker P M, Bierman P J, Fahey J L, Stein A S, Krance R A, Stock A D, Forman S J, Blume K G: Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes.J clin Oncol 5, 1822 (1987).

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Jens Pedersen-Bjergaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pedersen-Bjergaard, J. Therapy-related acute nonlymphocytic leukemia: Clinical aspects. Med. Oncol. & Tumor Pharmacother. 5, 207–209 (1988). https://doi.org/10.1007/BF03003186

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03003186

Search

Navigation